MYOK earnings call for the period ending March 31, 2019.
News & Analysis: MyoKardia
Canopy Growth Corporation, MyoKardia, and Blueprint Medicines are all outstanding healthcare picks this month.
Learn about 2019's first-day losers in the stock market.
A relatively modest secondary share offering proposal is lifting spirits.
These stocks helped push markets higher. Find out why.
Positive top-line results for mavacamten have the market pumped up today.